-+ 0.00%
-+ 0.00%
-+ 0.00%

WUHAN HITECK BIOLOGICAL PHARMA CO - TREATMENT-RELATED OCULAR ADVERSE EVENTS WERE MILD WITH NO STUDY WITHDRAWALS

Reuters·10/13/2026 11:09:01

Please log in to view news